A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...
Across all income levels, bariatric surgery resulted in better diabetes control than GLP-1s or similar medications, a study ...
One of the biggest risk factors for prediabetes is weight gain. Over the past several decades, rates of obesity have risen ...
The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.
Speaking at the J.P. Morgan conference, CEO David Ricks said he anticipates a “rapid review” for orforglipron that's ...
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis — a ...
GALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically ...
The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve ...
The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy, the first daily oral medication for obesity treatment. The once-daily tablet — ...
The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...
Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s work by ...
Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 drugs. Early trials suggest it improves blood sugar control and fat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback